0001209191-24-003423.txt : 20240215 0001209191-24-003423.hdr.sgml : 20240215 20240215203842 ACCESSION NUMBER: 0001209191-24-003423 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240209 FILED AS OF DATE: 20240215 DATE AS OF CHANGE: 20240215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novo Holdings A/S CENTRAL INDEX KEY: 0001388325 ORGANIZATION NAME: STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41949 FILM NUMBER: 24645547 BUSINESS ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 BUSINESS PHONE: 45 8824 8824 MAIL ADDRESS: STREET 1: TUBORG HAVNEVEJ 19 CITY: HELLERUP STATE: G7 ZIP: 2900 FORMER NAME: FORMER CONFORMED NAME: Novo A/S DATE OF NAME CHANGE: 20070130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Metagenomi, Inc. CENTRAL INDEX KEY: 0001785279 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813909017 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5959 HORTON STREET STREET 2: 7TH FLOOR CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 871-4880 MAIL ADDRESS: STREET 1: 5959 HORTON STREET STREET 2: 7TH FLOOR CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Metagenomi Technologies, LLC DATE OF NAME CHANGE: 20190812 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-09 1 0001785279 Metagenomi, Inc. MGX 0001388325 Novo Holdings A/S TUBORG HAVNEVEJ 19 HELLERUP G7 2900 DENMARK 0 0 1 0 0 COMMON STOCK 2024-02-09 4 P 0 100000 10.25 A 100000 D COMMON STOCK 2024-02-13 4 C 0 839175 A 939175 D COMMON STOCK 2024-02-13 4 P 0 800000 15.00 A 1739175 D SERIES B PREFERRED STOCK 2024-02-13 4 C 0 147415 D COMMON STOCK 147415 0 D SERIES B-1 PREFERRED STOCK 2024-02-13 4 C 0 691760 D COMMON STOCK 691760 0 D Each share of Series B Preferred Stock and Series B-1 Preferred Stock converted into Common Stock, on a one-for-one basis, automatically upon the closing of the Issuer's initial public offering without payment of additional consideration. These shares have no expiration date. Represents a purchase from the underwriters in the Issuer's initial public offering. /s/ Barbara Fiorini Due, General Counsel, Finance & Operations 2024-02-15